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Randomized Trial of Conventional Transseptal Needle Versus
Radiofrequency Energy Needle Puncture for Left Atrial Access
(the TRAVERSE-LA Study)
Jonathan C. Hsu, MD, MAS; Nitish Badhwar, MBBS; Edward P. Gerstenfeld, MD; Randall J. Lee, MD, PhD; Mala C. Mandyam, MD;
Thomas A. Dewland, MD; Kourtney E. Imburgia, BA; Kurt S. Hoffmayer, MD; Vasanth Vedantham, MD, PhD; Byron K. Lee, MD, MAS;
Zian H. Tseng, MD, MAS; Melvin M. Scheinman, MD; Jeffrey E. Olgin, MD; Gregory M. Marcus, MD, MAS
Background-—Transseptal puncture is a critical step in achieving left atrial (LA) access for a variety of cardiac procedures. Although
the mechanical Brockenbrough needle has historically been used for this procedure, a needle employing radiofrequency (RF)
energy has more recently been approved for clinical use. We sought to investigate the comparative effectiveness of an RF versus
conventional needle for transseptal LA access.
Methods and Results-—In this prospective, single-blinded, controlled trial, 72 patients were randomized in a 1:1 fashion to an RF
versus conventional (BRK-1) transseptal needle. In an intention-to-treat analysis, the primary outcome was time required for
transseptal LA access. Secondary outcomes included failure of the assigned needle, visible plastic dilator shavings from needle
introduction, and any procedural complication. The median transseptal puncture time was 68% shorter using the RF needle
compared with the conventional needle (2.3 minutes [interquartile range {IQR}, 1.7 to 3.8 minutes] versus 7.3 minutes [IQR, 2.7 to
14.1 minutes], P=0.005). Failure to achieve transseptal LA access with the assigned needle was less common using the RF versus
conventional needle (0/36 [0%] versus 10/36 [27.8%], P<0.001). Plastic shavings were grossly visible after needle advancement
through the dilator and sheath in 0 (0%) RF needle cases and 12 (33.3%) conventional needle cases (P<0.001). There were no
differences in procedural complications (1/36 [2.8%] versus 1/36 [2.8%]).
Conclusions-—Use of an RF needle resulted in shorter time to transseptal LA access, less failure in achieving transseptal LA
access, and fewer visible plastic shavings.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01209260. ( J Am Heart Assoc. 2013;2:
e000428 doi: 10.1161/JAHA.113.000428)
Key Words: Brockenbrough needle • comparative effectiveness • left atrial access • radiofrequency energy
needle • randomized controlled trial • transseptal puncture
T ransseptal puncture is commonly performed to achieveleft atrial (LA) access for a variety of common cardiac
procedures, including catheter ablation of atrial fibrillation
(AF),1 accessory pathways and ventricular tachycardia,2,3 LA
appendage closure,4,5 and mitral valve procedures.6,7 Histor-
ically, a conventional Brockenbrough needle has been used to
mechanically puncture the fossa ovalis, but adoption of a
newer transseptal needle using radiofrequency (RF) energy
applied to an insulated blunt-tipped electrode has increased
despite a prospective trial comparing the 2 strategies.
Although the conventional needle may provide more imme-
diate tactile feedback and has a longer track record of
success, the RF needle may be more effective in cases of an
elastic, aneurysmal, or thickened interatrial septum.8 In
addition, safety concerns have been raised as more plastic
particle shavings were observed after introduction of the
Brockenbrough versus the RF needle through the dilator and
sheath, suggesting that there may be a risk of plastic particle
embolization with the conventional needle.9 A large retro-
spective study found that the RF needle was faster, more
effective, and safer in achieving LA access,10 but a randomized
prospective comparison to the conventional needle has not
been performed.
The purpose of this study was to examine the effectiveness
and safety of an RF needle compared with a conventional
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Brockenbrough needle for transseptal LA access in a
prospective, randomized trial.
Methods
Trial Design and Patient Population
The Conventional Transseptal Needle Versus Radiofrequency
Energy Needle Puncture for Left Atrial Access (TRAVERSE-LA)
study was a single-blinded, randomized, controlled trial to
compare the effectiveness and safety of transseptal puncture
using an RF needle versus a conventional Brockenbrough in
patients undergoing catheter ablation procedures requiring LA
access.
Between January 2011 and November 2012, 72 patients
were randomized in a 1:1, single-blinded fashion to 1 of 2
transseptal needle groups. Intraprocedural measurements
were prospectively obtained at the bedside by study person-
nel. Patients undergoing catheter ablation procedures involv-
ing a planned transseptal puncture were included if they were
≥18 years of age and able to consent to the research study.
Patients were excluded from the study if transesophageal
echocardiography performed before the procedure revealed a
patent foramen ovale large enough to alter the strategy for
transseptal LA access (such as the planned use of the ablator
to probe the interatrial septum). All patients provided
informed, written, and witnessed consent. The study protocol
was approved by the Committee on Human Research of the
University of California, San Francisco.
Study Protocol and Transseptal Puncture
The transseptal puncture was performed by a cardiac
electrophysiology fellow and attending electrophysiologist
via right femoral venous access. Intracardiac echocardio-
graphy (ICE) using a 9-F Ultra ICE catheter (Boston Scientific)
or an8-FAcuNav ultrasound catheter (BiosenseWebster) guided
the transseptal puncture. Patients randomized to the RF
needle group underwent transseptal puncture with a large,
preformed curve 71-cm-C1 or 98-cm-C1 18-gauge NRG
needle (Baylis Medical) through a 63-cm Fast-Cath SL1
sheath (St. Jude Medical) or a 71-cm large curl Agilis NxT
Steerable Introducer sheath (St. Jude Medical). Sheaths were
selected at the discretion of the operating physician prior to
knowledge of treatment assignment. The RF needle diameter
was 18 gauge proximally and 21 gauge distally and had a
blunt distal uninsulated electrode tip for RF energy transmis-
sion. The needle was fully insulated throughout its course,
except for the electrode tip. A grounding pad was placed on
the left thigh. The RFP 100-115 RF Puncture Generator (Baylis
Medical) was attached to the grounding pad and RF needle
using a connector cable and was set to an output power of
10 W for 2 seconds. The generator produced continuous
monopolar RF power output at a fixed frequency of
500 kHz. Patients randomized to the conventional nee-
dle group underwent transseptal puncture with either a large,
preformed curve 71- or 98-cm 18-gauge BRK-1 needle
(St. Jude Medical) through the same sheaths listed above.
The BRK-1 needle had a shoulder 3 mm proximal to the
introducer tip, designed to prevent the needle from advancing
too far.
In preprocedural ex vivo testing of both needle groups, the
transseptal needle and sheath were flushed with heparinized
saline before use, and the transseptal needle was placed
through the dilator and sheath until the tip of the needle could
be visualized. The transseptal needles were not modified or
manually shaped prior to placement through the dilator and
sheath. In the conventional needle arm, the inner stylet was
removed prior to advancement through the dilator and
sheath. The transseptal needle was then removed, and the
dilator and sheath were flushed again. Operators and study
personnel looked for any evidence of grossly visible plastic
particles, recorded as yes versus no (a “yes” answer required
agreement between the operator and study personnel
present).
The transseptal sheath and dilator were then advanced to
the superior vena cava over a guidewire under fluoroscopic
visualization. The guidewire was removed, and the contents of
the dilator were evacuated and then flushed with heparinized
saline. The transseptal needle was then flushed with hepa-
rinized saline, inserted into the dilator and sheath, and
advanced under fluoroscopic guidance until the needle tip was
located 2 to 5 mm proximal to the dilator tip. The needle,
dilator, and sheath were pulled down as a unit (beginning of
the time of measurement for the primary outcome) until
tenting of the fossa ovalis was confirmed using ICE. Contrast
injection and fluoroscopy were also used to verify the needle
location. Holding the dilator and sheath still, the needle was
then advanced out of the dilator, and contrast was injected. If
LA access was not obtained after initial needle advancement
in the conventional needle arm, the entire apparatus was
advanced as a unit to puncture the septum with the needle;
for the RF needle arm, RF energy was applied at 10 W for
2 seconds. If necessary, additional applications of RF energy
were delivered to obtain LA access. LA access was confirmed
by the operators on the basis of contrast media visualized in
the LA under fluoroscopy and microbubbles observed in the
LA with ICE. The dilator and sheath were then advanced
over the needle into the LA under fluoroscopic and ICE
visualization (end of the time of measurement for the primary
outcome).
The initial study protocol allowed application of monopolar
RF energy using an electrosurgical pencil (Covidien) or “bovie”
set to “cut” at 35 W and applied to the proximal needle handle
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of the BRK-1 needle in those who failed transseptal LA access
with mechanical attempts.11 However, the protocol was
amended after enrollment of the 10th patient to exclude this
practice after the publication of a study suggested that
application of electrocautery to the BRK-1 needle may result
in coring and embolizaton of septal tissue.12
Data Collection and Study Outcome Measures
The primary outcome was total time required for LA access for
the first transseptal puncture, defined as time from the first
pull-down of the needle/sheath/dilator apparatus in the
superior vena cava to first entrance of the sheath into the left
atrium. Secondary outcome measures included other efficacy
measures (failure of the assigned needle type, time from
interatrial septum engagement to sheath advancement, and
time from needle advancement to sheath advancement) and
safety measures (presence of visible plastic dilator shavings
from needle introduction and any procedural complication
plausibly related to transseptal puncture). Procedural compli-
cations plausibly related to transseptal needle puncture
included aortic puncture, pericardial effusion, stroke or
systemic embolization, and death. The assigned needle type
was determined to fail when further attempts to achieve LA
access were deemed to be either futile or unsafe per the
discretion of the operator. All patients were monitored for
both intraprocedural complications and postprocedural
complications until discharge.
Statistical Analysis
We targeted a sample size of 72 (36 in each randomization
group) in order to achieve 80% power to detect a 5-minute
reduction in total transseptal puncture time (assuming a
standard deviation of 7.5 minutes) using a 2-sided alpha level
of 0.05. The primary analysis was performed on an inten-
tion-to-treat basis. An exploratory per-protocol analysis
restricted to participants who maintained their initial needle
assignment (ie, excluding crossover patients) was also
performed. Normally distributed continuous variables are
expressed as means and standard deviations, whereas
continuous variables with skewed distributions are expressed
as medians and interquartile ranges (IQRs). Baseline patient
characteristics and outcome measures were compared
between assigned needle groups using the v2 test for
categorical variables and t tests or the Wilcoxon rank-sum
test for continuous variables, as appropriate. A linear
regression analysis using log-transformed transseptal time
(due to right-skewed data) was used to identify predictors of
transseptal time. Covariates were selected for inclusion in
multivariable models if their univariate association with the
outcome reached P<0.20. Statistical tests were 2-sided and
considered significant if they yielded a P<0.05. Analyses were
performed using Stata version 11.1 (College Station, TX).
Results
Baseline Characteristics
We enrolled a total of 72 patients undergoing planned LA
access via a transseptal puncture; 36 patients were randomly
assigned to the RF needle and 36 to the conventional BRK-1
needle (Figure 1). There were no significant differences in
baseline patient demographic and clinical characteristics
between the 2 study arms (Table 1). Twenty-two patients
(30.6%) had a previous transseptal puncture a median of 536
days (IQR, 173 to 1167 days) before the index procedure.
Contrary to the protocol, 3 conventional needle patients were
initially unsuccessful and ultimately resulted in LA access only
after electrocautery energy was applied to the proximal
needle handle. These patients were included in all analyses as
part of the conventional needle arm and were not considered
failures or crossover patients.
Primary and Secondary Outcomes
As seen in Figure 2, the median transseptal puncture time
was 68% shorter using the RF needle compared with the
conventional needle (2.3 minutes [IQR, 1.7 to 3.8 minutes]
versus 7.3 minutes [IQR, 2.7 to 14.1 minutes], P=0.005). In
additional analyses, the mean transseptal puncture time
trended toward a shorter overall time using the RF needle
compared with the conventional needle (5.210.2 versus
9.08.2 minutes, P=0.086). Median transseptal puncture
times were also shorter in the RF needle arm from
engagement of the fossa ovalis to the long sheath in the
LA and needle tip out of the long sheath to the long sheath
in the LA (Table 2). Of the 36 patients randomized to the RF
needle arm, 27 (75.0%) required RF application an average
of 1.20.6 times to achieve LA access. Per-protocol
analysis (ie, excluding crossovers) showed statistically
significantly shorter median transseptal puncture times in
the RF needle arm from engagement of the fossa ovalis
(1.3 minutes [IQR, 0.7 to 1.9 minutes] versus 2.4 minutes
[IQR, 1.2 to 4.7 minutes], P=0.003) and from first advancing
the needle out of the long sheath (0.8 minutes [IQR, 0.4 to
1.2 minutes] versus 1.5 minutes [IQR, 0.7 to 2.2 minutes],
P=0.012).
Failure to achieve transseptal LA access with the assigned
needle was less common using the RF needle compared with
the conventional needle (0/36 [0%] versus 10/36 [27.8%],
P<0.001). Although a larger proportion of patients with a
previous transseptal puncture failed with the conventional
needle, this did not reach statistical significance (4/10 [40%]
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versus 6/26 [23.1%], P=0.31). In all 10 failures, crossover
occurred because of an inability to puncture the interatrial
septum despite forward pressure and tenting, leading to
concern that further effort might lead to perforation of the
free (lateral) LA wall. Of the 7 operators who enrolled patients
in the study, 5 operators experienced failure of the assigned
conventional needle. The 7 operators differed in their
preference of and experience with each type of needle prior
to study initiation (Table 3). In the RF needle arm, transseptal
LA access was initially unsuccessful in 1 patient despite
engagement of the interatrial septum and application of the
RF pulse, resulting in crossover to the conventional needle.
However, after failure of the conventional needle, the RF
needle was attempted again, this time resulting in successful
LA access after 1 RF pulse.
With ex vivo preprocedural testing involving advancement
of the assigned transseptal needle through the plastic dilator
and sheath, the RF needle created grossly visible plastic
shavings less often than the conventional needle (0 [0%]
versus 12/36 [33.3%], P<0.001). An example of plastic dilator
shavings seen after introduction of the conventional needle
through the dilator and long sheath is shown in Figure 3.
Procedural complications were no different between the RF
and conventional needle groups (1/36 [2.8%] versus 1/36
[2.8%], P=1.000). In the RF needle arm, 1 patient was found to
have a pericardial effusion detected by ICE after conclusion of
the LA ablation procedure (3 hours after the transseptal
puncture). In the conventional needle arm, 1 patient experi-
enced a transient ischemic attack with brain magnetic
resonance imaging consistent with embolic etiology.
Predictors of Transseptal Time
Multivariable linear regression analysis revealed that older
patient age, increased attending physician experience, use of
the conventional needle, and radial-view ICE were each
significantly associated with longer transseptal time
(Table 4).
Discussion
TRAVERSE-LA is the first randomized comparison of an RF
versus conventional needle for transseptal puncture. The RF
needle significantly reduced time to transseptal LA access,
resulted in less failure of the assigned needle, and produced
fewer visible plastic shavings from introduction of the needle
through the dilator and sheath. Procedural complications did
not differ between needle groups.
Transseptal puncture for LA access is becoming more
common because of the growing adaptation of catheter
ablation and structural heart procedures involving left-sided
access.1–7 However, the transseptal puncture procedure can
be time consuming13,14 and can result in important compli-
cations.15,16 Prolonged transseptal procedures may increase
Figure 1. Subject flow in the study. *Patients available for analysis of the primary outcome of time of first transseptal puncture. There were no
patients excluded from the analysis. RF indicates radiofrequency.
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Table 1. Baseline Patient, Operator, and Procedural Characteristics
Characteristic Conventional Needle Group (n=36) RF Needle Group (n=36) P Value
Patient demographic characteristics
Age, y 61.111.7 59.911.3 0.668
Male sex 23 (63.9) 25 (69.4) 0.617
Race 0.392
White 33 (91.7) 33 (91.7)
Black 1 (2.8) 0 (0.0)
Asian 1 (2.8) 0 (0.0)
Other 1 (2.8) 3 (8.3)
Body mass index, kg/m2 28.44.7 28.45.9 0.995
Hypertension 20 (55.6) 20 (55.6) 1.000
Diabetes 4 (11.1) 5 (13.9) 0.722
Coronary artery disease 4 (11.1) 5 (13.9) 0.722
Congestive heart failure 3 (8.3) 3 (8.3) 1.000
Previous stroke or transient ischemic attack 3 (8.3) 2 (5.6) 0.643
Atrial fibrillation 35 (97.2) 35 (97.2) 1.000
Atrial fibrillation type 0.563
Paroxysmal 27 (77.1) 29 (82.9)
Persistent 7 (20.0) 6 (17.1)
Long-standing persistent 1 (2.9) 0 (0.0)
History of atrial flutter 6 (16.7) 9 (25.0) 0.384
History of atrial tachycardia 1 (2.8) 1 (2.8) 1.000
Wolff–Parkinson–White syndrome 1 (2.8) 1 (2.8) 1.000
Indication for transseptal puncture 1.000
Atrial fibrillation 35 (97.2) 35 (97.2)
Accessory pathway 1 (2.8) 1 (2.8)
Previous transseptal puncture 10 (27.8) 12 (33.3) 0.609
Left atrial size* 0.844
Normal 8 (29.6) 6 (25.0)
Mildly enlarged 5 (18.5) 7 (29.2)
Moderately enlarged 8 (29.6) 6 (25.0)
Severely enlarged 6 (22.2) 5 (20.8)
Operator-related characteristics
Operator experience, days
Fellow-in-training experience 395.2169.4 433.3165.4 0.337
Attending physician experience 3389.81377.3 3553.01458.3 0.627
Procedural characteristics
Intracardiac echocardiography 0.759
Phased-array ultrasound 30 (83.3) 29 (80.6)
Radial-view ultrasound 6 (16.7) 7 (19.4)
Biplane fluoroscopy 33 (91.7) 31 (86.1) 0.453
Long sheath for transseptal needle 0.555
SL1 long sheath 35 (97.2) 34 (94.4)
Agilis steerable long sheath 1 (2.8) 2 (5.6)
Values are reported as meanSD or n (%). RF indicates radiofrequency; SD, standard deviation.
*Proportions were calculated on the basis of patients with echocardiographic data available in each arm.
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total procedure times and ionizing radiation exposure to the
patient and operator because of the high-intensity fluoroscopy
that is often employed. Finally, personnel and electrophysi-
ology laboratory time may become both clinically and
financially relevant at the extremes of differences in trans-
septal time, particularly if it means staffing overtime is used or
the “next case” is postponed for another day.
An observational study describing the initial experience
using the RF needle reported a 97.2% success rate (35 of 36)
in achieving transseptal access, but no comparator group was
included.17 Subsequently, a larger observational study sug-
gested that the RF needle may result in shorter procedure
times, better efficacy of achieving LA access, and decreased
complications.10 However, data were analyzed retrospec-
tively, and patients were not randomized to needle therapy.
As the RF needle was used more recently and therefore
potentially in a more experienced electrophysiology labora-
tory, the results may have been biased in favor of the RF
needle.
We found that RF compared with conventional needle use
resulted in a 68% shorter median time to transseptal LA
access; this amounted to an absolute 5-minute median
difference and more than a 10-minute upper quartile differ-
ence in transseptal puncture time between the 2 arms.
However, the absolute time difference may not be particularly
large in light of the whole procedure. Indeed, we observed no
difference in total procedure or fluoroscopy time between
groups. Of note, the RF application itself was quite short; the
75% of patients who required RF usage for transseptal LA
access needed an average of 1.20.6 applications, translat-
ing into an approximate mean of 2.41.2 seconds of total RF
application time. Subanalyses examining several points during
the first transseptal puncture, including time from fossa ovalis
engagement to long sheath across and needle out of the
sheath to long sheath across, found that the RF needle
consistently resulted in shorter transseptal times in both
intention-to-treat and per-protocol analyses. It is interesting
to note that the variability of transseptal time appeared to be
largest in the conventional group (as can be seen in Figure 2),
suggesting that the timing differences were driven primarily
by the more difficult cases in the conventional group versus a
more uniform experience in the RF group.
To assess predictors of transseptal time, we constructed
multivariable models with covariates plausibly associated with
the outcome. After adjustment, use of the RF needle was one
of the strongest predictors of a shorter transseptal time. Use
of radial-view ICE was associated with longer transseptal
Figure 2. Total transseptal puncture procedure time by assigned
transseptal needle. Box plots show the median (white line) and
interquartile range (from top to bottom of the box plot). Each whisker
represents the most extreme value within 1.5 times the interquartile
range. Outlier values are not shown. Times are inclusive of crossover
time.
Table 2. Procedural Outcomes
Outcome Conventional Needle Group (n=36) RF Needle Group (n=36) P Value
Transseptal-related procedural outcomes (minutes)*
Time from pulling down from superior vena cava to sheath in LA 7.3 (2.7 to 14.1) 2.3 (1.7 to 7.3) 0.005
Time from interatrial septum engagement to sheath in LA 2.8 (1.4 to 8.5) 1.3 (0.7 to 1.9) <0.001
Time from needle first out of dilator to sheath in LA 1.9 (0.8 to 7.6) 0.8 (0.4 to 1.2) <0.001
Total procedure-related outcomes (minutes)
Total procedure time 356.571.3 347.482.3 0.615
Total fluoroscopy time 52.618.8 54.121.0 0.747
Values are reported as median (IQR) or meanSD. IQR indicates interquartile range; LA, left atrium; RF, radiofrequency; SD, standard deviation.
*Times are inclusive of crossover time.
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times, suggesting that the higher-resolution view of the fossa
ovalis obtained with phased-array ICE rather than the more
global atrial view obtained with the radial-view system may be
particularly useful during these procedures. Older patient age
also predicted longer transseptal times, perhaps because of
more distorted cardiac anatomy or more interatrial septal
fibrosis. Counter to expectations, increased attending physi-
cian experience was also associated with longer transseptal
times, perhaps related to a more cautious approach taken by
experienced operators.
Randomization to the RF needle resulted in success in all
patients, whereas randomization to the conventional needle
resulted in 10 crossover patients, all of whom were subse-
quently successful using the RF needle. Because this was a
single-blinded study and the operator made the final decision
to crossover based on safety reasons, inadvertent bias may
have occurred. However, we found that crossover of patients
from the conventional to RF needle was distributed across
operators, many of whom personally preferred to use the
conventional needle prior to the study (Table 3). Therefore, it
is not clear why bias (or lack of blinding) would not have
similarly led to more crossovers from the RF to the
conventional needle. Although the proportion of patients
who failed transseptal puncture with the conventional needle
was higher than reported in previous studies, it is noteworthy
that all previous studies on the subject have been retrospec-
tive.10,16 It is important to emphasize that this is the first
study to prospectively enroll and then follow transseptal
puncture patients with research personnel in the room before
and throughout the case to carefully track successes and
failures. It is possible that difficult or failed transseptal
puncture attempts in previous retrospective studies were not
included or missed. Finally, although not statistically signif-
icant, 40% of those who failed with the conventional needle
(and succeeded with the RF needle) had a previous transsep-
tal puncture, a previously established predictor of a difficult
procedure.13 However, given this large difference and previ-
ous evidence that repeat transseptal punctures are more
challenging, the RF needle may be particularly preferred in the
repeat transseptal puncture population. In fact, we used a
conservative estimate when designating “failure” of the
assigned transseptal needle: 3 additional patients assigned
to the conventional needle had difficulty in achieving LA
access despite forward pressure and tenting, and based on
operator discretion, application of electrocautery to the
conventional needle was performed against protocol, each
time resulting in success. Although successful transseptal
puncture has been described in the literature based on this
technique,11 we changed the study protocol to preclude this
practice after the study was already under way based on
Figure 3. Pictured is an example of grossly visible particles that
were produced after the introduction of a conventional needle
through the dilator and long sheath. The particles are placed on
conventional electrocardiography paper as a size reference.
Table 3. Operator Characteristics Before and During Transseptal Needle Study
Operator ID
Years of Experience
With BRK-1 Needle
Before Study
Years of Experience
With RF Needle
Before Study
Preferred Needle
Before Study
Number of Patients in
Study Randomized to
BRK-1 Needle
Number of Patients in
Study Randomized
to RF Needle
Number of Crossover
Patients From BRK-1 to
RF Needle
1 18 1 BRK-1 4 5 3
2 10 0 BRK-1 2 6 1
3 10 0 BRK-1 4 0 0
4 8 2 RF 18 17 4
5 7 2 BRK-1 2 1 1
6 5 2 RF 5 7 2
7 1 1 RF 1 0 0
ID indicates identification; RF, radiofrequency.
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evidence of tissue coring and the theoretical risk of embolism
that can occur with this technique.12
We found that the RF needle was less likely to produce
visible plastic shavings after introduction into the dilator and
sheath. The most plausible mechanism for this difference is
that the conventional needle has a sharp tip, whereas the RF
needle tip is blunt. Feld et al9 reported that the production of
plastic shavings measured by light microscopy occurred less
commonly with RF needles than with conventional needles.
Our study is the first prospective, randomized trial to confirm
these findings and quantitate the prevalence of this phenom-
enon in a clinical setting. In the conventional needle arm, we
performed ex vivo testing without the stylet in the needle,
which is the standard of care at our institution. We performed
shaving in this manner to mimic the course of the needle
through the dilator/sheath outside the patient’s body. In fact,
our method of conventional needle introduction without the
stylet and with forward flushing is the most common method
employed in published reports,10,13,16 and is reflected in the
original report of shaved visible particles.9 We acknowledge
that the frequency of plastic shavings might be reduced if the
stylet is left in place until the needle/stylet tip is close to the
dilator tip; however, removing the stylet within the body may
increase the risk of air embolism and does not preclude
unseen shaving production from the unprepared distal
portion of the dilator. Future studies are needed to evaluate
whether plastic shavings are dislodged during transseptal
procedures, even after the dilator and sheath are prepped in
the absence of the stylet, potentially leading to clinical
sequelae. Complications did not differ between the RF and
conventional needle arms. It is important to emphasize that
ICE was used to guide transseptal puncture in all cases in this
trial and that risks may be higher if the RF needle is used in
the absence of ICE.
Study Limitations
Several limitations should be acknowledged. First, this study
included a relatively small number of patients. We calculated
the sample size necessary to meet the primary outcome of
the study a priori, and a lack of power should not result in
spurious false-positive results. However, lack of power could
result in failure to detect certain real relationships, such as
important predictors of transseptal time in multivariable
models. Second, the reasons for the high rate of LA access
failure in the conventional needle study arm are unclear and
could represent unique aspects of the patient population
studied that may not be generalizable to general practice.
Third, we only used the BRK-1 needle manufactured by St.
Jude Medical in the conventional needle arm of this study.
Conventional needles manufactured by different companies
may have other characteristics that could affect transseptal
puncture success. Fourth, our study did not involve other
novel protocols in the event of conventional needle failure,
such as use of electrocautery applied to a conventional needle
or a nitinol guidewire (SafeSept, Pressure Products Inc)
through the lumen of the conventional needle.18 Finally,
despite finding that use of the RF needle resulted in shorter
transseptal puncture time, less failure, and fewer plastic
shavings, the RF needle is generally more expensive than the
conventional needle, suggesting that a formal cost-effective-
ness study is warranted.
Table 4. Univariate and Multivariable Analyses of Predictors Associated With Transseptal Time
Variable
Univariate Analysis Multivariable Analysis
Percent Increase in
Transseptal Time* (95% CI) P Value
Percent Increase in
Transseptal Time* (95% CI) P Value
Age (per 10-year increase) 15.4% (5.1 to 35.9) 0.138 18.2% (1.6 to 34.8) 0.032
Previous transseptal puncture 34.1% (16.6 to 84.8) 0.184 31.0% (10.0 to 72.1) 0.136
Radial view intracardiac ultrasound 87.5% (29.6 to 145.3) 0.004 79.6% (29.6 to 129.7) 0.002
Attending physician experience (per 1-year increase) 9.8% (4.1 to 15.5) 0.001 8.3% (3.2 to 13.3) 0.002
Conventional needle 67.8% (23.3 to 112.2) 0.003 73.3% (35.8 to 110.9) <0.001
Male sex 22.0% (71.9 to 27.9) 0.381 † —
Congestive heart failure 29.2% (114.5 to 56.1) 0.497 † —
Fellow physician experience (per 1-year increase) 5.2% (57.1 to 46.7) 0.842 † —
Biplane fluoroscopy 34.8% (39.9 to 109.6) 0.356 † —
CI indicates confidence interval.
*The b coefficient from regression analyses represents the percent increase in transseptal time per unit increase of continuous predictor variables or as associated with individual
categorical variables.
†Covariates failing to meet criteria for inclusion in the multivariable model (as described in the Methods section).
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Conclusions
Use of an RF needle resulted in shorter time to transseptal LA
access, less failure in achieving transseptal LA access, and
fewer visible plastic shavings. There were no differences in
clinically recognized complications.
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